A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
for Non-obstructive Hypertrophic Cardiomyopathy
Sites in Oak Lawn, Chicago +20 more locations
Sponsor: Imbria Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07023614·Phase 2·Recruiting·Listed Jun 2025